Roquefort Therapeutics plc (ROQ.L)
GBp 1.7
(0.0%)
GBp 1.7
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 589.02 Thousand GBP | 4.89% |
| 2022 | 561.58 Thousand GBP | 17.63% |
| 2021 | 477.42 Thousand GBP | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.14 Million GBP | 94.33% |
| 2024 Q2 | 1.14 Million GBP | 0.0% |
| 2023 Q4 | 589.02 Thousand GBP | 91.79% |
| 2023 FY | 589.02 Thousand GBP | 4.89% |
| 2023 Q3 | 307.11 Thousand GBP | -52.91% |
| 2023 Q2 | 652.2 Thousand GBP | 76.13% |
| 2023 Q1 | 370.29 Thousand GBP | -34.06% |
| 2022 Q3 | 279.67 Thousand GBP | -79.68% |
| 2022 Q2 | 1.37 Million GBP | 25.76% |
| 2022 FY | 561.58 Thousand GBP | 17.63% |
| 2022 Q4 | 561.58 Thousand GBP | 100.8% |
| 2022 Q1 | 1.09 Million GBP | 129.23% |
| 2021 Q2 | 14.33 Thousand GBP | 0.0% |
| 2021 Q4 | 477.42 Thousand GBP | 0.0% |
| 2021 FY | 477.42 Thousand GBP | 0.0% |
| 2021 Q1 | 14.33 Thousand GBP | 0.0% |
| 2020 Q3 | - GBP | 0.0% |
| 2020 Q4 | - GBP | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|